Human Monoclonal Antibodies Reactive to Oligodendrocytes Promote Remyelination in a Model of Multiple Sclerosis

Proceedings of the National Academy of Sciences of the United States of America - United States
doi 10.1073/pnas.97.12.6820
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Proceedings of the National Academy of Sciences

Related search

Monoclonal Antibodies in Multiple Sclerosis: Present and Future

Biomedicines
BiochemistryMedicineGeneticsMolecular Biology
2019English

Estrogen Receptor Β Ligand Therapy Activates PI3K/Akt/mTOR Signaling in Oligodendrocytes and Promotes Remyelination in a Mouse Model of Multiple Sclerosis

Neurobiology of Disease
Neurology
2013English

Differential Sensitivity of Oligodendrocytes and Motor Neurons to Reactive Nitrogen Species: Implications for Multiple Sclerosis

Journal of Neurochemistry
BiochemistryMolecular NeuroscienceCellular
2009English

Remyelination in Multiple Sclerosis: Realizing a Long-Standing Challenge

Expert Review of Neurotherapeutics
NeuroscienceNeurologyPharmacology
2015English

Cross-Reactive Monoclonal Antibodies to Multiple HIV-1 Subtype and SIVcpz Envelope Glycoproteins

Virology
Virology
2009English

Survival and Functionality of Human Induced Pluripotent Stem Cell-Derived Oligodendrocytes in a Nonhuman Primate Model for Multiple Sclerosis

Stem cells translational medicine
MedicineDevelopmental BiologyCell Biology
2016English

The Extracellular Matrix and Remyelination Strategies in Multiple Sclerosis

eNeuro
MedicineNeuroscience
2018English

Monoclonal Antibodies to Human Sperm Antigens

Journal of Reproductive Immunology
GynecologyReproductive MedicineImmunologyObstetricsAllergy
1982English

Blueprint for the Development of Remyelination Medicines for Multiple Sclerosis

Clinical Neurology
Neurology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy